Industrial Machinery company 3M India announced Q3FY24 results:<br><br>Consolidated Q3FY24 vs Q3FY23:<br>- Sales & other operating Income: Rs 1,006 crore in Q3FY24, up by 1% from Rs 993 crore in Q3FY23.<br>- Other income: Rs 17 crore in Q3FY24, up by 42% from Rs 12 crore in Q3FY23.<br>- EBITDA: Rs 195 crore in Q3FY24, a 7% increase from Rs 183 crore in Q3FY23.<br>- PBT: Rs 181 crore in Q3FY24, up by 8% from Rs 167 crore in Q3FY23.<br>- PAT: Rs 135 crore in Q3FY24, showing an 8% increase from Rs 125 crore in Q3FY23.<br><br>Consolidated Q3FY24 vs Q2FY24:<br>- Sales & other operating income: Rs 1,006 crore in Q3FY24, down by 3% from Rs 1,040 crore in Q2FY24.<br>- Other income: Rs 17 crore in both quarters, no change.<br>- EBITDA: Rs 195 crore in Q3FY24, a 7% decrease from Rs 210 crore in Q2FY24.<br>- PBT: Rs 181 crore in Q3FY24, an 8% decrease from Rs 196 crore in Q2FY24.<br>- PAT: Rs 135 crore in Q3FY24, showing an 8% decrease from Rs 146 crore in Q2FY24.<br><br>Standalone Q3FY24 vs Q3FY23:<br>- Sales & other operating income: Rs 942 crore in Q3FY24, up by 1% from Rs 932 crore in Q3FY23.<br>- Other income: Rs 14 crore in Q3FY24, up by 27% from Rs 11 crore in Q3FY23.<br>- EBITDA: Rs 181 crore in Q3FY24, a 9% increase from Rs 166 crore in Q3FY23.<br>- PBT: Rs 167 crore in Q3FY24, up by 11% from Rs 151 crore in Q3FY23.<br>- PAT: Rs 125 crore in Q3FY24, showing an 11% increase from Rs 113 crore in Q3FY23.<br><br>Standalone Q3FY24 vs Q2FY24:<br>- Sales & other operating income: Rs 942 crore in Q3FY24, down by 3% from Rs 975 crore in Q2FY24.<br>- Other income: Rs 14 crore in Q3FY24, down by 7% from Rs 15 crore in Q2FY24.<br>- EBITDA: Rs 181 crore in Q3FY24, a 6% decrease from Rs 193 crore in Q2FY24.<br>- PBT: Rs 167 crore in Q3FY24, a 7% decrease from Rs 179 crore in Q2FY24.<br>- PAT: Rs 125 crore in Q3FY24, showing a 7% decrease from Rs 134 crore in Q2FY24.<br><br>Commenting on the consolidated financial result for the quarter and nine months ended December 31, 2023, Ramesh Ramadurai, Managing Director of 3M India, said, “The Company delivered 1.3% sales growth in the current quarter versus prior year, and a decline of 3.3% on a sequential basis. The Company delivered an 8.3% growth in Proft Before Tax versus prior year with PBT margin of 17.7%. For the nine months ended December 31, 2023, the Company delivered sales growth of 6.2% and PBT growth of 30.1%. Business trends broadly remained steady versus the previous quarter, though some softness was observed in the Health Care segment.”<br><br><br><br>Result PDF